$4.1 million funding supports epilepsy treatment research using spider venom proteins

UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins. 

Led by Professor Ernst Wolvetang, the project aims to prove the safety and efficacy of venom-based drugs by testing them on lab-grown brain and heart organoids grown from the cells of epilepsy patients. 

The research aims to pave the way for human clinical trials and to establish organoids as a tool that can be used to test experimental treatments and therapies. 

The funding has been provided through the MRFF's Stem Cell Therapies grant scheme. 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The role of the gut microbiota in multiple sclerosis: A scientometric analysis reveals key research trends